Literature DB >> 24048854

Cyclooxygenase-1-dependent prostaglandins mediate susceptibility to systemic inflammation-induced acute cognitive dysfunction.

Éadaoin W Griffin1, Donal T Skelly, Carol L Murray, Colm Cunningham.   

Abstract

Systemic inflammatory events often precipitate acute cognitive dysfunction in elderly and demented populations. Delirium is a highly prevalent neuropsychiatric syndrome that is characterized by acute inattention and cognitive dysfunction, for which prior dementia is the major predisposing factor and systemic inflammation is a frequent trigger. Inflammatory mechanisms of delirium remain unclear. We have modeled aspects of delirium during dementia by exploiting progressive neurodegeneration in the ME7 mouse model of prion disease and by superimposing systemic inflammation induced by the bacterial endotoxin lipopolysaccharide (LPS). Here, we have used this model to demonstrate that the progression of underlying disease increases the incidence, severity, and duration of acute cognitive dysfunction. This increasing susceptibility is associated with increased CNS expression of cyclooxygenase (COX)-1 in microglia and perivascular macrophages. The COX-1-specific inhibitor SC-560 provided significant protection against LPS-induced cognitive deficits, and attenuated the disease-induced increase in hippocampal and thalamic prostaglandin E2, while the COX-2-specific inhibitor NS-398 was ineffective. SC-560 treatment did not alter levels of the proinflammatory cytokines interleukin (IL)-1β, tumor necrosis factor-α, IL-6, or C-X-C chemokine ligand 1 in blood or brain, but systemic IL-1RA blocked LPS-induced cognitive deficits, and systemic IL-1β was sufficient to induce similar deficits in the absence of LPS. Furthermore, the well tolerated COX inhibitor ibuprofen was protective against IL-1β-induced deficits. These data demonstrate that progressive microglial COX-1 expression and prostaglandin synthesis can underpin susceptibility to cognitive deficits, which can be triggered by systemic LPS-induced IL-1β. These data contribute to our understanding of how systemic inflammation and ongoing neurodegeneration interact to induce cognitive dysfunction and episodes of delirium.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24048854      PMCID: PMC3776067          DOI: 10.1523/JNEUROSCI.6361-11.2013

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  60 in total

Review 1.  Anti-inflammatory actions of peroxisome proliferator-activated receptor gamma agonists in Alzheimer's disease.

Authors:  G E Landreth; M T Heneka
Journal:  Neurobiol Aging       Date:  2001 Nov-Dec       Impact factor: 4.673

Review 2.  Cyclooxygenase-2: regulation and relevance in inflammation.

Authors:  J A Mitchell; S Larkin; T J Williams
Journal:  Biochem Pharmacol       Date:  1995-11-09       Impact factor: 5.858

3.  Impaired adrenocorticotropic hormone response to bacterial endotoxin in mice deficient in prostaglandin E receptor EP1 and EP3 subtypes.

Authors:  Yoko Matsuoka; Tomoyuki Furuyashiki; Haruhiko Bito; Fumitaka Ushikubi; Yasuhiro Tanaka; Takuya Kobayashi; Seiji Muro; Noriko Satoh; Tetsuro Kayahara; Mikito Higashi; Akira Mizoguchi; Hitoshi Shichi; Yoshihiro Fukuda; Kazuwa Nakao; Shuh Narumiya
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-17       Impact factor: 11.205

4.  Involvement of arachidonic acid cascade in working memory impairment induced by interleukin-1 beta.

Authors:  Yuji Matsumoto; Taku Yamaguchi; Shigenori Watanabe; Tsuneyuki Yamamoto
Journal:  Neuropharmacology       Date:  2004-06       Impact factor: 5.250

5.  Microsomal prostaglandin E synthase-1 is the central switch during immune-induced pyresis.

Authors:  David Engblom; Sipra Saha; Linda Engström; Marie Westman; Laurent P Audoly; Per-Johan Jakobsson; Anders Blomqvist
Journal:  Nat Neurosci       Date:  2003-10-19       Impact factor: 24.884

6.  Synaptic changes characterize early behavioural signs in the ME7 model of murine prion disease.

Authors:  C Cunningham; R Deacon; H Wells; D Boche; S Waters; C Picanco Diniz; H Scott; J N P Rawlins; V H Perry
Journal:  Eur J Neurosci       Date:  2003-05       Impact factor: 3.386

Review 7.  Interactions of PGH synthase isozymes-1 and -2 with NSAIDs.

Authors:  W L Smith; E A Meade; D L DeWitt
Journal:  Ann N Y Acad Sci       Date:  1994-11-15       Impact factor: 5.691

Review 8.  Pharmacology of prostaglandin endoperoxide synthase isozymes-1 and -2.

Authors:  W L Smith; E A Meade; D L DeWitt
Journal:  Ann N Y Acad Sci       Date:  1994-04-18       Impact factor: 5.691

Review 9.  Delirium superimposed on dementia: a systematic review.

Authors:  Donna M Fick; Joseph V Agostini; Sharon K Inouye
Journal:  J Am Geriatr Soc       Date:  2002-10       Impact factor: 5.562

10.  Role of arachidonate metabolism in the immunoregulatory function of human leukocytic pyrogen/lymphocyte-activating factor/interleukin 1.

Authors:  C A Dinarello; S O Marnoy; L J Rosenwasser
Journal:  J Immunol       Date:  1983-02       Impact factor: 5.422

View more
  44 in total

1.  Serotonin as a putative scavenger of hypohalous acid in the brain.

Authors:  Mike Kalogiannis; E James Delikatny; Thomas M Jeitner
Journal:  Biochim Biophys Acta       Date:  2015-12-14

2.  Identification of Specific Components of the Eicosanoid Biosynthetic and Signaling Pathway Involved in Pathological Inflammation during Intra-abdominal Infection with Candida albicans and Staphylococcus aureus.

Authors:  Mélanie A C Ikeh; Paul L Fidel; Mairi C Noverr
Journal:  Infect Immun       Date:  2018-06-21       Impact factor: 3.441

3.  Systemic lipopolysaccharide administration impairs retrieval of context-object discrimination, but not spatial, memory: Evidence for selective disruption of specific hippocampus-dependent memory functions during acute neuroinflammation.

Authors:  Jennifer Czerniawski; Teiko Miyashita; Gail Lewandowski; John F Guzowski
Journal:  Brain Behav Immun       Date:  2014-10-19       Impact factor: 7.217

Review 4.  The interface between delirium and dementia in elderly adults.

Authors:  Tamara G Fong; Daniel Davis; Matthew E Growdon; Asha Albuquerque; Sharon K Inouye
Journal:  Lancet Neurol       Date:  2015-06-29       Impact factor: 44.182

5.  Statins for delirium in ICU patients: a negative trial but a positive step.

Authors:  Peter W Lange; Andrea B Maier
Journal:  J Thorac Dis       Date:  2016-09       Impact factor: 2.895

6.  Does prior sepsis alter subsequent circadian and sickness behaviour response to lipopolysaccharide treatment in mice?

Authors:  Sean T Anderson; Emma K O'Callaghan; Sean Commins; Andrew N Coogan
Journal:  J Neural Transm (Vienna)       Date:  2013-12-15       Impact factor: 3.575

7.  Possible roles of COX-1 in learning and memory impairment induced by traumatic brain injury in mice.

Authors:  J L Shang; Q Cheng; W F Yang; M Zhang; Y Cui; Y F Wang
Journal:  Braz J Med Biol Res       Date:  2014-09-16       Impact factor: 2.590

8.  A Role for the Adenosine ADORA2B Receptor in Midazolam Induced Cognitive Dysfunction.

Authors:  Jennifer Gile; Yoshimasa Oyama; Sydney Shuff; Tobias Eckle
Journal:  Curr Pharm Des       Date:  2020       Impact factor: 3.116

9.  The Period 2 Enhancer Nobiletin as Novel Therapy in Murine Models of Circadian Disruption Resembling Delirium.

Authors:  Jennifer Gile; Benjamin Scott; Tobias Eckle
Journal:  Crit Care Med       Date:  2018-06       Impact factor: 7.598

10.  (R)-Ketamine attenuates LPS-induced endotoxin-derived delirium through inhibition of neuroinflammation.

Authors:  Jiancheng Zhang; Li Ma; Xiayun Wan; Jiajing Shan; Youge Qu; Kenji Hashimoto
Journal:  Psychopharmacology (Berl)       Date:  2021-07-27       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.